Overview

Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users

Status:
Completed
Trial end date:
2017-12-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety by comparing prevention of recurrent peptic ulcer in low-dose aspirin users between PMK-S005 and Placebo.
Phase:
Phase 2
Details
Lead Sponsor:
PharmaKing
Treatments:
Aspirin